N@N

HGSI, XL, UNM, MPEL, AUO, EMN Expected To Be Lower Leading Up To Next Earnings Releases

^{Published on 2009-10-20 11:18:42, Last Modified on 2010-12-22 17:10:38 - WOPRAI}
 

October 21, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and October/November earnings reports. Human Genome Sciences (NASDAQ: HGSI), XL Capital (NYSE: XL), Unum Group (NYSE: UNM), Melco Crown Entertainment (NASDAQ: MPEL), AU Optronics (NYSE: AUO) and Eastman Chemical (NYSE: EMN) are all expected to be lower leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower leading up to their next earnings release:

Symbol Company # of Reports Quarter Release Date

HGSI Human Genome Sciences 12 quarters Q3 10/28/2009

XL XL Capital Ltd. October earnings Q3 10/28/2009

UNM Unum Group 12 quarters Q3 11/3/2009

MPEL Melco Crown Entertain 12 quarters Q3 11/12/2009

AUO AU Optronics Corp. October earnings Q3 10/22/2009

EMN Eastman Chemical 12 quarters Q3 10/22/2009

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Human Genome Sciences, Inc. (NASDAQ: HGSI) operates as a biopharmaceutical company in the United States. The companya�s clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, and cancer. It focuses on the commercialization of Albuferon (albinterferon alfa-2b) for hepatitis C and LymphoStat-B (belimumab) for lupus. The company has completed Phase III development trials for Albuferon and is conducting two Phase III clinical trials of LymphoStat-B. It also delivers doses of ABthrax (raxibacumab) to the U.S. Strategic National Stockpile for use in the event of an emergency for the treatment of inhalation anthrax. In addition, the company has various drugs in the earlier stages of clinical development for the treatment of cancer, led by the TRAIL receptor antibody HGS-ETR1 and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. Further, Human Genome Sciences, Inc., through a strategic collaboration agreement with GlaxoSmithKline, has substantial financial rights to certain products in the GlaxoSmithKline clinical pipeline, including darapladib that is in Phase III development as a treatment for coronary heart disease; and Syncria (albiglutide), which is in Phase III development as a treatment for type 2 diabetes. Additionally, it has a strategic commercial collaboration agreement with Novartis International Pharmaceutical, Ltd. for the co-development and commercialization of Albuferon; and a strategic licensing and collaboration agreement with Aegera Therapeutics, Inc. to develop and commercialize HGS1029 and other small-molecule inhibitors of IAP (inhibitor of apoptosis) proteins in oncology. Human Genome Sciences, Inc. was founded in 1992 and is headquartered in Rockville, Maryland.

XL Capital Ltd (NYSE: XL), through its subsidiaries, provides insurance and reinsurance coverages to industrial, commercial, and professional service firms, as well as insurance companies and other enterprises worldwide. The company operates through four segments: Insurance, Reinsurance, Life Operations, and Other Financial lines. Its Insurance segment offers risk management products, including property and casualty insurance programs, umbrella liability, products recall, workersa� compensation, property catastrophe, and primary master property and liability coverages; and specialty lines products comprising professional liability, environmental liability, aviation and satellite, marine and offshore, equine, and other insurance coverages. The companya�s Reinsurance segment provides treaty and facultative reinsurance to primary insurers of casualty and property risks, including general liability, professional liability, automobile and workersa� compensation, commercial and personal property risks, property catastrophe, property excess of loss, property pro-rata, marine and energy, aviation and satellite, and various other reinsurance, as well as specialty risks comprising fidelity and surety, and ocean marine. Its Life Operations segment offers a range of underlying lines of life assurance, including term assurances, group life, critical illness cover, immediate annuities, disability income cover, and short-term accident and health, as well as life reinsurance. XL Capitala�s Other Financial lines segment comprises guaranteed investment contract (GIC) and funding agreement (FA) businessses. GICs and FAs provide users with guaranteed rates of interest on amounts invested with the company. The company was formerly known as EXEL Limited and changed its name to XL Capital Ltd in February 1999. XL Capital was founded in 1986 and is headquartered in Hamilton, Bermuda.

Unum Group (NYSE: UNM), together with its subsidiaries, provides group and individual disability insurance products in the United States and the United Kingdom. The company also provides a portfolio of other insurance products, including long-term care insurance, life insurance, employer and employee-paid group benefits, and related services. It offers group long-term and short-term disability; group life and accidental death, and dismemberment; individual disability; group and individual long-term care; voluntary benefits; group and individual life; accident, sickness, and disability; and cancer and critical illness insurance products. The company also provides individual life and corporate-owned life insurance, reinsurance pools and management operations, group pension, health insurance, and individual annuities, as well as offers brokerage voluntary benefits. It markets its products primarily to employers interested in providing benefits to their employees. The company was formerly known as UnumProvident Corporation and changed its name to Unum Group in February 2007. Unum Group was founded in 1848 and is based in Chattanooga, Tennessee.

Melco Crown Entertainment Limited (NASDAQ: MPEL), through its subsidiaries, engages in the development, ownership, and operation of casino gaming and entertainment resort facilities in Macau. The company owns and operates Crown Macau resort that features a casino area of approximately 183,000 square feet with approximately 255 gaming tables and 95 gaming machines, as well as hotel rooms, fine dining and casual restaurants, recreation and leisure facilities, and meeting facilities; Mocha Clubs, which provide single player machines with various games, including progressive jackpots; and multi-player games where players on linked machines play against each other in electronic roulette, baccarat, and sicbo. As of March 9, 2009, the company operated 8 Mocha Clubs in Macau with a total of approximately 1,345 gaming machines. In addition, it owns and operates Taipa Square Casino with approximately 18,300 sq. ft. of gaming space and features approximately 31 gaming tables servicing rolling chip and mass market patrons. Further, Melco Crown Entertainment is developing City of Dreams project, an integrated urban entertainment resort, combining casino with hotel offerings, entertainment venues, a performance theatre, retail, and food and beverage outlets. The company was formerly known as Melco PBL Entertainment (Macau) Limited and changed its name to Melco Crown Entertainment Limited in May 2008. Melco Crown Entertainment Limited was incorporated in 2004 and is based in Central, Hong Kong.

AU Optronics Corp. (NYSE: AUO) engages in the design, development, manufacture, assembly, and marketing of thin film transistor liquid crystal display (TFT-LCD) panels and other flat panel displays. The company's TFT-LCD panels are used in computer products, such as notebook computers and desktop monitors; consumer electronics products comprising mobile phones, digital photo frames, digital still cameras, portable navigation display, portable digital versatile disk players, digital camcorders, automobile display, and amusement and printer displays; and LCD televisions and industrial displays. It sells its panels principally to original equipment manufacturing service providers in Taiwan, the Peoplea�s Republic of China, and internationally. The company was formerly known as Acer Display Technology, Inc. and changed its name to AU Optronics Corp. in May 2001. AU Optronics Corp. was founded in 1996 and is based in Hsinchu, Taiwan.

Eastman Chemical Company (NYSE: EMN) engages in manufacturing and selling chemicals, plastics, and fibers in the United States. The company operates in five segments: Coatings, Adhesives, Specialty Polymers, and Inks (CASPI); Fibers; Performance Chemicals and Intermediates (PCI); Performance Polymers; and the Specialty Plastics (SP). The CASPI segment manufactures liquid vehicles, additives, specialty polymers, and other raw materials that are used in paints and coatings, inks, adhesives, and other formulated products. The Fibers segment offers Estron acetate tow and Estrobond triacetin plasticizers used in cigarette filters; Estron natural and Chromspun solution-dyed acetate yarns for use in apparel, home furnishings, and industrial fabrics; and cellulose acetate flake and acetyl raw materials for acetate fiber producers. The PCI segment offers intermediates; performance chemicals; and complex organic molecules, such as diketene derivatives, specialty ketones, and specialty anhydrides for pharmaceutical, fiber, and food and beverage ingredients, which are used in specialty market applications. This segmenta�s products are used in various markets and end uses, including agrochemical, automotive, beverages, nutrition, pharmaceuticals, medical devices, toys, photographic and imaging, household products, polymers, textiles, and industrials. The Performance Polymers segment provides polyethylene terephthalate for use in beverage and food packaging, as well as in custom-care and cosmetics packaging, health care and pharmaceutical uses, household products, carpet fibers, and industrial packaging applications. The SP segment offers cellulosic plastics and specialty copolyesters, which are used in specialty packaging, in-store fixtures and displays, consumer and durable goods, medical goods, personal care and consumer packaging, photographic film, optical film, fibers/nonwovens, tapes/labels, and LCDa�s. The Company was founded in 1920 and is headquartered in Kingsport, Tennessee.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641